APY Aspyra,

Aspyra, Inc. (AMEX: APY) today announced plans to demonstrate the latest release of AccessRAD, their integrated RIS/PACS product at the upcoming RSNA 2009 Annual Meeting held at McCormick Place in Chicago, IL (November 29 – December 3, 2009), Booth 3021, South Building Hall A.

The latest release of Aspyra’s AccessRAD RIS/PACS, version 6.5.0, includes performance improvement features for accessing and reading radiological images and new methods for creating, printing, and scanning of registration forms and modality questionnaires; an improved scheduling process, and more efficient method of rescheduling or canceling of patient exams. A key feature of AccessRAD RIS/PACS v6.5 also features the ability to create internal orders for studies sent from outside referring facilities diagnostic interpretation via DICOM transfer protocols. These orders are automatically are processed by the RIS, thereby optimizing workflow, as well as increasing revenue by preventing lost charges due to missing or incorrect orders. Reports created for these outside studies can have tailored report templates which retain the other facilities medical record and exam number. Once signed by the radiologist the reports then can be automatically sent back to the outside facility via fax or HL7 data transmission.

Bill Culton, Aspyra’s Diagnostic Solutions Product Manager states, “Many of our customers are forming relationships with outside facilities to read studies for them. Our interoperability with other PACS system allows them receive DICOM studies and have our system automatically create internal orders from them giving them a efficient and labor-less outside study workflow. We will also be demonstrating our interoperability with RADAR a critical results management system.”

Aspyra’s AccessRAD RIS/PACS (Radiology Information System / Picture Archive Communication System) is designed to meet the needs of acute care hospitals, enterprise-wide delivery networks, and medium to large imaging centers, with end-to-end solutions that automate processes at every point of patient and imaging encounter workflow.

Safe Harbor Statement

This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for Aspyra’s markets and the demand for its products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of today the date of this press release, including management's own knowledge and assessment of the Company’s industry and competition. Factors that could cause Aspyra’s actual results to differ materially from these forward-looking statements include among others: the competitive environment; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in our long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.

Aspyra (AMEX:APY)
過去 株価チャート
から 11 2024 まで 12 2024

Aspyra (AMEX:APY)
過去 株価チャート
から 12 2023 まで 12 2024